Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006

World Journal of Surgery

Volumn 34, Issue 6, 2010, Pages 1239-1246

  Grant, Clive S ^a   Stulak, John M ^a   Thompson, Geoffrey B ^a   Richards, Melanie L ^a   Reading, Carl C ^a   Hay, Ian D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PAPILLARY CARCINOMA; POSTOPERATIVE COMPLICATION; RISK FACTOR; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHILD; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 77955551436     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0307-9     Document Type: Article

References (32)

1. Hay ID, Grant CS, Taylor WF et al (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095
2. Hay I, Thompson G, Grant C et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879-885
3. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953
4. American Thyroid Association Guidelines Task Force (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1-33
5. Thyroid Carcinoma Task Force (2001) AACE/AAES medical/ surgical guidelines for clinical practice: management of thyroid carcinoma-American Association of Clinical Endocrinologists, American College of Endocrinology. Endocr Pract 7:203-220
6. Bilimoria K, Bentrem D, Ko Cet al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:275-384
7. Anonymous (2007) Thyroid carcinoma. In: NCCN clinical practice guidelines in oncology. 2.2007 ed. www.nccn.org
8. Greene F, Page D, Fleming I et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
9. Fleming I, Cooper J, Henson D (eds) (1997) American Joint Committee on cancer: AJCC cancer staging manual. Lippincott- Raven, Philadelphia
10. Hay ID, Bergstralh EJ, Goellner JR et al (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058.
11. DeGroot L, Kaplan E, McCormick M et al (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
12. Moley J, Wells S (1999) Compartment-mediated dissection for papillary thyroid cancer. Langenbecks Arch Surg 384:9-15
13. Anonymous (2008) Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19:ii99-ii101
14. Zimmerman D, Hay I, Gough I et al (1988) Papillary thyroid cancer in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157-1166
15. Vassilopoulou-Sellin R, Schultz P, Haynie T (1996) Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 78:493-501
16. Mazzaferri E, Young R, Oertel J et al (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171-196
17. Lundgren C, Hall P, Dickman P et al (2005) Clinically significant prognostic factors for differentiated thyroid carcinoma. Cancer 106:524-531
18. Loh KC, Greenspan F, Gee L et al (1997) Pathological tumornode- metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 82:3553-3562
19. Gagel R, Goepfert H, Callender D (1996) Changing concepts in the pathogenesis and management of thyroid carcinoma. CA Cancer J Clin 46:261-283
20. Voutilainen P, Multanen M, Leppaniemi A et al (2001) Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid 11:953-957
21. Heemstra K, Liu Y, Stokkel M et al (2007) Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 66:58-64
22. Mazzaferri E (2007) Management of low-risk differentiated thyroid cancer. Endocr Pract 13:498-512
23. Kloos R, Mazzaferri E (2005) A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 90:5047-5057
24. Sawka A, Thephamongkhol K, Brouwers M et al (2004) A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668-3676
25. Stulak J, Grant C, Farley D et al (2006) Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 141:489-496
26. Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000-1007
27. Bonnet S, Hartl D, Leboulleux S et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162-1167
28. Noguchi S, Murakami N (1987) The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 67:251-261
29. Ozaki O, Kunihiko I, Kobayashi K et al (1988) Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 12:825-829
30. Hay I, Bergstralh E, Grant C et al (1999) Impact of primary surgery on outcome in 300 patients with pathologic tumor-nodemetastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery 126:1173
31. Roh JL, Park JY, Park C (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245:604-610
32. Porterfield J, Factor D, Grant C (2009) Operative technique for modified radical neck dissection in papillary thyroid carcinoma. Arch Surg 144:567-574